MA Binding Protein YTHDF2 in Cancer

Overview

Journal Exp Hematol Oncol

Publisher Biomed Central

Specialty Hematology

Date 2022 Apr 6

PMID 35382893

Authors

Xiaomin Chen

Xiangxiang Zhou

Xin Wang

Affiliations

Soon will be listed here.

Abstract

YT521-B homology domain family member 2 (YTHDF2) is an N-methyladenosine (mA)-binding protein that was originally found to regulate the stability of mRNA. Growing evidence has shown that YTHDF2 can participate in multifarious bioprocesses, including embryonic development, immune response, and tumor progression. Furthermore, YTHDF2 is closely associated with the proliferation, apoptosis, invasion, and migration of tumor cells, suggesting its significant role in cancers. YTHDF2 primarily relies on mA modification to modulate signaling pathways in cancer cells. However, the expression and function of YTHDF2 in human malignancies remain controversial. Meanwhile, the underlying molecular mechanisms of YTHDF2 have not been elucidated. In this review, we principally summarized the biological functions and molecular mechanisms of YTHDF2 in tumors and discussed its prognostic and therapeutic values.

Citing Articles

ZHX2 inhibits diabetes-induced liver injury and ferroptosis by epigenetic silence of YTHDF2.

Meng W, Li L Nutr Diabetes. 2025; 15(1):6.

PMID: 39987125 PMC: 11846978. DOI: 10.1038/s41387-025-00355-0.

The role of N(6)-methyladenosine (m6a) modification in cancer: recent advances and future directions.

Xie X, Fang Z, Zhang H, Wang Z, Li J, Jia Y EXCLI J. 2025; 24:113-150.

PMID: 39967906 PMC: 11830918. DOI: 10.17179/excli2024-7935.

Endogenous peptide CBDP1 inhibits clear cell renal cell carcinoma progression by targeting USP5/YTHDF2/TRPM5 axis.

Zhang Y, Zhu W, Tao R, Li W, Jiang C, Yan X J Transl Med. 2025; 23(1):116.

PMID: 39863860 PMC: 11763126. DOI: 10.1186/s12967-025-06091-4.

N-Methyladenosine Modification on the Function of Female Reproductive Development and Related Diseases.

Cui X, Li H, Huang X, Xue T, Wang S, Zhu X Immun Inflamm Dis. 2024; 12(12):e70089.

PMID: 39660878 PMC: 11632877. DOI: 10.1002/iid3.70089.

Ythdf2 facilitates precursor miR-378/miR-378-5p maturation to support myogenic differentiation.

Deng K, Su Y, Liu Z, Hu S, Ren C, Wei W Cell Mol Life Sci. 2024; 81(1):445.

PMID: 39503763 PMC: 11541164. DOI: 10.1007/s00018-024-05456-0.

References

Einstein J, Perelis M, Chaim I, Meena J, Nussbacher J, Tankka A . Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer. Mol Cell. 2021; 81(15):3048-3064.e9. PMC: 8359670. DOI: 10.1016/j.molcel.2021.06.014. View

Meyer K, Jaffrey S . Rethinking mA Readers, Writers, and Erasers. Annu Rev Cell Dev Biol. 2017; 33:319-342. PMC: 5963928. DOI: 10.1146/annurev-cellbio-100616-060758. View

Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X . Histone lactylation drives oncogenesis by facilitating mA reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021; 22(1):85. PMC: 7962360. DOI: 10.1186/s13059-021-02308-z. View

Hsu P, Zhu Y, Ma H, Guo Y, Shi X, Liu Y . Ythdc2 is an N-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017; 27(9):1115-1127. PMC: 5587856. DOI: 10.1038/cr.2017.99. View

Zhang C, Huang S, Zhuang H, Ruan S, Zhou Z, Huang K . YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 2020; 39(23):4507-4518. DOI: 10.1038/s41388-020-1303-7. View

Yu W, Zhang X, Zhang W, Xiong M, Lin Y, Chang M . 19-Hydroxybufalin inhibits non-small cell lung cancer cell proliferation and promotes cell apoptosis via the Wnt/β-catenin pathway. Exp Hematol Oncol. 2021; 10(1):48. PMC: 8543904. DOI: 10.1186/s40164-021-00243-0. View

Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J . Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2014; 116(1):35-45. PMC: 4282610. DOI: 10.1161/CIRCRESAHA.115.304457. View

Li M, Zhao X, Wang W, Shi H, Pan Q, Lu Z . Ythdf2-mediated mA mRNA clearance modulates neural development in mice. Genome Biol. 2018; 19(1):69. PMC: 5984442. DOI: 10.1186/s13059-018-1436-y. View

Dixit D, Prager B, Gimple R, Poh H, Wang Y, Wu Q . The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells. Cancer Discov. 2020; 11(2):480-499. PMC: 8110214. DOI: 10.1158/2159-8290.CD-20-0331. View

10.

Yang Z, Li J, Feng G, Gao S, Wang Y, Zhang S . MicroRNA-145 Modulates -Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the -Methyladenosine Binding YTH Domain Family 2 Protein. J Biol Chem. 2017; 292(9):3614-3623. PMC: 5339747. DOI: 10.1074/jbc.M116.749689. View

11.

Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y . Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019; 21(4):498-510. DOI: 10.1038/s41556-019-0299-0. View

12.

Tsuchiya K, Yoshimura K, Inoue Y, Iwashita Y, Yamada H, Kawase A . YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer. Oncoimmunology. 2021; 10(1):1962656. PMC: 8366544. DOI: 10.1080/2162402X.2021.1962656. View

13.

Jin D, Guo J, Wu Y, Yang L, Wang X, Du J . mA demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020; 19(1):40. PMC: 7045432. DOI: 10.1186/s12943-020-01161-1. View

14.

Zhang C, Zhang M, Ge S, Huang W, Lin X, Gao J . Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer. Cancer Med. 2019; 8(10):4766-4781. PMC: 6712480. DOI: 10.1002/cam4.2360. View

15.

Hines M, Coffre M, Mudianto T, Panduro M, Wigton E, Tegla C . miR-29 Sustains B Cell Survival and Controls Terminal Differentiation via Regulation of PI3K Signaling. Cell Rep. 2020; 33(9):108436. PMC: 7730937. DOI: 10.1016/j.celrep.2020.108436. View

16.

Du C, Lv C, Feng Y, Yu S . Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression. J Exp Clin Cancer Res. 2020; 39(1):223. PMC: 7576758. DOI: 10.1186/s13046-020-01735-3. View

17.

Zhuang J, Lin C, Ye J . m A RNA methylation regulators contribute to malignant progression in rectal cancer. J Cell Physiol. 2020; 235(9):6300-6306. DOI: 10.1002/jcp.29626. View

18.

Zhang J, He X, Wan Y, Zhang H, Tang T, Zhang M . CD44 promotes hepatocellular carcinoma progression via upregulation of YAP. Exp Hematol Oncol. 2021; 10(1):54. PMC: 8603576. DOI: 10.1186/s40164-021-00247-w. View

19.

Zhao T, Sun D, Zhao M, Lai Y, Liu Y, Zhang Z . N-methyladenosine mediates arsenite-induced human keratinocyte transformation by suppressing p53 activation. Environ Pollut. 2020; 259:113908. PMC: 7082205. DOI: 10.1016/j.envpol.2019.113908. View

20.

Henslee A, Steele T . Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia. Biomark Res. 2018; 6:26. PMC: 6085711. DOI: 10.1186/s40364-018-0140-0. View